Plain-English translation of NCT06519331 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are developing a new way to measure how stiff your liver is using a device called FibroScan. Liver stiffness is an important sign of liver damage and scarring. This study will help doctors improve how they measure this in patients with various types of liver disease.
Currently available methods for measuring liver stiffness have limitations. This study aims to create a better, more reliable technique that could help doctors diagnose and monitor liver disease more accurately in the future.
You likely qualify if…
You likely don't qualify if…
You will receive a FibroScan examination, which is a painless ultrasound-based test that measures how stiff your liver is. The scan involves placing a small probe on your skin over the liver area. The study takes place at specialized liver disease centers in France and involves 114 adult patients total.
AI-generated summary from trial data · Jul 17, 2026 · Not medical advice
France
Sponsor
Echosens
Enrollment target
~114 participants
Started
November 2024
Primary completion
October 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Anne Llorca
Echosens
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.